Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2025-10-03 00:00:00 ET · period of report 2025-10-01 · accession 0000875320-25-000224 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-03 | 2025-10-02 | VRTX | Biller Jonathan | EVP, CLO | S - Sale | $404.21 | -694 | 15.7K | -4% | -$280.5K | |
| 2025-10-03 | 2025-10-01 | VRTX | Biller Jonathan | EVP, CLO | F - Tax | $400.00 | -1,259 | 16.3K | -7% | -$503.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-02 | S | D | 694 | $404.21 | 15,653 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-01 | F | D | 1,259 | $400.00 | 16,347 | D | — | — |